Myeloid Suppressor Cell Interaction

Myeloid Suppressor Cell Interaction is the relationship between tumors and myeloid-derived suppressor cells, an immature, developmentally arrested population of myeloid precursor cells whose differentiation into mature neutrophils or monocytes has been blocked by sustained tumor-derived signaling, leaving them in a distinctively immunosuppressive state rather than progressing to the mature, more functionally specialized macrophage and neutrophil phenotypes discussed elsewhere. This developmental arrest is the defining feature distinguishing myeloid-derived suppressor cells from the tumor-associated macrophages and tumor-associated neutrophils examined separately: those populations represent mature cells whose function has been polarized by the tumor microenvironment, while myeloid-derived suppressor cells represent an immature population that never fully completed the maturation process to begin with, and this arrested state itself confers particularly potent suppressive capacity.

Origin Through Blocked Emergency Myelopoiesis

Under normal conditions, myeloid precursors in the bone marrow differentiate in an orderly fashion into mature neutrophils and monocytes before entering circulation. Sustained exposure to tumor-derived factors including granulocyte-macrophage colony-stimulating factor, granulocyte colony-stimulating factor, interleukin-6, and prostaglandin E2 drives a state of pathological emergency myelopoiesis, expanding the myeloid precursor pool substantially while simultaneously blocking its normal terminal differentiation, producing large numbers of immature cells that are released into circulation and recruited to the tumor in this arrested state rather than as fully matured effector cells.

Two Principal Subsets

Myeloid-derived suppressor cells are classified into two principal subsets: polymorphonuclear (PMN-MDSCs), sharing substantial phenotypic and developmental overlap with the immature end of the neutrophil spectrum discussed under tumor associated neutrophil interaction, and monocytic (M-MDSCs), similarly overlapping with immature monocyte populations that would otherwise mature into the macrophage lineage. Despite this overlap, both subsets are distinguished functionally from their mature counterparts by markedly greater per-cell immunosuppressive potency, reflecting their arrested developmental state rather than representing a simply less-differentiated but otherwise equivalent version of the mature cell type.

Suppressive Mechanisms Distinct From Other Myeloid Populations

Myeloid-derived suppressor cells deploy several mechanisms that, while sharing some overlap with tumor-associated macrophage and neutrophil suppressive activity, are particularly characteristic of this population:

• Arginase-1-mediated arginine depletion, in which high arginase-1 expression rapidly consumes extracellular arginine, a metabolite required for T cell receptor signaling and proliferation, effectively starving nearby T cells of an essential metabolic substrate.
• Inducible nitric oxide synthase (iNOS) activity, generating nitric oxide that can directly nitrate T cell receptor components and other signaling proteins, impairing T cell function through a distinct, arginine-independent chemical mechanism.
• Reactive oxygen species production, contributing oxidative suppression of T cell function through mechanisms overlapping with the general oxidative stress pathways discussed under the cancer cell stress response, but here directed outward at neighboring immune cells rather than affecting the myeloid-derived suppressor cell's own internal state.
• Cystine and cysteine sequestration, in which myeloid-derived suppressor cells import cystine but do not export the resulting cysteine back into the extracellular space as most cells do, depriving nearby T cells (which cannot synthesize cysteine independently and depend on this exchange) of an amino acid required for glutathione synthesis and proliferation.

Because arginase-1, iNOS, and reactive oxygen species production can all be simultaneously elevated within the same myeloid-derived suppressor cell population, these mechanisms frequently act in combination, producing a metabolic and oxidative suppressive environment considerably more comprehensive than any single mechanism would achieve alone.

Clinical Correlation With Prognosis and Treatment Resistance

Elevated circulating and tumor-infiltrating myeloid-derived suppressor cell abundance has been consistently associated with worse prognosis and with reduced responsiveness to checkpoint inhibitor immunotherapy across numerous cancer types, consistent with this population's role in directly suppressing the cytotoxic T cell activity that checkpoint inhibitors are intended to restore; a tumor with abundant myeloid-derived suppressor cell infiltration may retain robust T cell suppression through this mechanism even after checkpoint blockade has successfully removed the specific PD-1/PD-L1-mediated restraint discussed under cytotoxic T cell interaction, illustrating that multiple independent suppressive mechanisms operating simultaneously can each independently limit the efficacy of a therapy targeting only one of them.

Therapeutic Strategies

Because myeloid-derived suppressor cells represent an arrested developmental state rather than a terminally differentiated one, several therapeutic strategies aim to force completion of differentiation rather than to deplete the population outright, including all-trans retinoic acid, which has been shown experimentally to promote maturation of myeloid-derived suppressor cells into less suppressive, more mature myeloid cell types. Additional strategies target the specific suppressive enzymes directly, including phosphodiesterase-5 inhibitors (which reduce arginase and iNOS activity) and STAT3 pathway inhibitors (targeting a transcription factor central to the emergency myelopoiesis program described above), reflecting a therapeutic approach aimed at reversing or blocking the developmental arrest itself rather than simply eliminating the cells that arrest has produced.